Cross Country Healthcare, Inc. (CCRN)
USD 14.38
(0.35%)
USD 14.38
(0.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 679.31 Million USD | -28.33% |
| 2022 | 947.83 Million USD | 29.34% |
| 2021 | 732.8 Million USD | 105.28% |
| 2020 | 356.97 Million USD | -6.64% |
| 2019 | 382.37 Million USD | -10.45% |
| 2018 | 427 Million USD | -8.7% |
| 2017 | 467.68 Million USD | 20.42% |
| 2016 | 388.37 Million USD | 6.09% |
| 2015 | 366.09 Million USD | 12.6% |
| 2014 | 325.13 Million USD | 30.79% |
| 2013 | 248.58 Million USD | -18.74% |
| 2012 | 305.92 Million USD | -8.93% |
| 2011 | 335.91 Million USD | -3.53% |
| 2010 | 348.2 Million USD | -2.35% |
| 2009 | 356.58 Million USD | -16.26% |
| 2008 | 425.84 Million USD | -20.45% |
| 2007 | 535.3 Million USD | 6.2% |
| 2006 | 504.03 Million USD | 4.64% |
| 2005 | 481.66 Million USD | 5.63% |
| 2004 | 455.99 Million USD | -3.95% |
| 2003 | 474.72 Million USD | 21.54% |
| 2002 | 390.59 Million USD | 7.91% |
| 2001 | 361.97 Million USD | 13.96% |
| 2000 | 317.62 Million USD | 2.56% |
| 1999 | 309.69 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 648.43 Million USD | -4.55% |
| 2024 Q2 | 602.88 Million USD | -7.03% |
| 2023 FY | 679.31 Million USD | -28.33% |
| 2023 Q3 | 707.73 Million USD | -8.22% |
| 2023 Q1 | 920.54 Million USD | -2.88% |
| 2023 Q4 | 679.31 Million USD | -4.02% |
| 2023 Q2 | 771.13 Million USD | -16.23% |
| 2022 Q1 | 916.43 Million USD | 25.06% |
| 2022 Q2 | 938.96 Million USD | 2.46% |
| 2022 FY | 947.83 Million USD | 29.34% |
| 2022 Q4 | 947.83 Million USD | 7.4% |
| 2022 Q3 | 882.51 Million USD | -6.01% |
| 2021 Q4 | 732.8 Million USD | 40.81% |
| 2021 Q3 | 520.42 Million USD | 5.43% |
| 2021 Q2 | 493.63 Million USD | 11.59% |
| 2021 FY | 732.8 Million USD | 105.28% |
| 2021 Q1 | 442.35 Million USD | 23.92% |
| 2020 Q3 | 357.83 Million USD | 1.6% |
| 2020 Q4 | 356.97 Million USD | -0.24% |
| 2020 FY | 356.97 Million USD | -6.64% |
| 2020 Q1 | 386.97 Million USD | 1.2% |
| 2020 Q2 | 352.2 Million USD | -8.99% |
| 2019 Q1 | 441.43 Million USD | 3.38% |
| 2019 Q2 | 396.96 Million USD | -10.07% |
| 2019 Q4 | 382.37 Million USD | -2.95% |
| 2019 Q3 | 393.99 Million USD | -0.75% |
| 2019 FY | 382.37 Million USD | -10.45% |
| 2018 FY | 427 Million USD | -8.7% |
| 2018 Q4 | 427 Million USD | -6.55% |
| 2018 Q3 | 456.93 Million USD | -0.49% |
| 2018 Q2 | 459.2 Million USD | -0.13% |
| 2018 Q1 | 459.79 Million USD | -1.69% |
| 2017 FY | 467.68 Million USD | 20.42% |
| 2017 Q4 | 467.68 Million USD | 2.42% |
| 2017 Q3 | 456.65 Million USD | 19.39% |
| 2017 Q2 | 382.49 Million USD | 3.83% |
| 2017 Q1 | 368.39 Million USD | -5.15% |
| 2016 Q3 | 364.73 Million USD | 5.92% |
| 2016 Q2 | 344.36 Million USD | -4.35% |
| 2016 FY | 388.37 Million USD | 6.09% |
| 2016 Q4 | 388.37 Million USD | 6.48% |
| 2016 Q1 | 360.04 Million USD | -1.65% |
| 2015 Q4 | 366.09 Million USD | 7.76% |
| 2015 Q2 | 331.65 Million USD | -0.55% |
| 2015 FY | 366.09 Million USD | 12.6% |
| 2015 Q3 | 339.72 Million USD | 2.43% |
| 2015 Q1 | 333.49 Million USD | 2.57% |
| 2014 Q2 | 341.37 Million USD | 31.37% |
| 2014 Q1 | 259.85 Million USD | 4.54% |
| 2014 Q3 | 336.46 Million USD | -1.44% |
| 2014 Q4 | 325.13 Million USD | -3.37% |
| 2014 FY | 325.13 Million USD | 30.79% |
| 2013 Q3 | 275.49 Million USD | 0.35% |
| 2013 Q2 | 274.52 Million USD | -2.44% |
| 2013 Q1 | 281.39 Million USD | -8.02% |
| 2013 FY | 248.58 Million USD | -18.74% |
| 2013 Q4 | 248.58 Million USD | -9.77% |
| 2012 Q1 | 334.65 Million USD | -0.37% |
| 2012 FY | 305.92 Million USD | -8.93% |
| 2012 Q2 | 317.25 Million USD | -5.2% |
| 2012 Q4 | 305.92 Million USD | 1.52% |
| 2012 Q3 | 301.33 Million USD | -5.02% |
| 2011 Q4 | 335.9 Million USD | -2.9% |
| 2011 Q1 | 343.72 Million USD | -1.29% |
| 2011 Q3 | 345.94 Million USD | 0.02% |
| 2011 Q2 | 345.87 Million USD | 0.63% |
| 2011 FY | 335.91 Million USD | -3.53% |
| 2010 Q1 | 354.42 Million USD | -0.61% |
| 2010 FY | 348.2 Million USD | -2.35% |
| 2010 Q3 | 356.87 Million USD | 0.98% |
| 2010 Q4 | 348.2 Million USD | -2.43% |
| 2010 Q2 | 353.41 Million USD | -0.28% |
| 2009 Q3 | 367.76 Million USD | -6.32% |
| 2009 FY | 356.58 Million USD | -16.26% |
| 2009 Q4 | 356.58 Million USD | -3.04% |
| 2009 Q2 | 392.55 Million USD | -6.1% |
| 2009 Q1 | 418.04 Million USD | -1.83% |
| 2008 Q4 | 425.84 Million USD | -36.19% |
| 2008 Q2 | 533.22 Million USD | -0.58% |
| 2008 Q1 | 536.34 Million USD | 0.19% |
| 2008 FY | 425.84 Million USD | -20.45% |
| 2008 Q3 | 667.34 Million USD | 25.15% |
| 2007 FY | 535.3 Million USD | 6.2% |
| 2007 Q2 | 508.55 Million USD | 0.23% |
| 2007 Q4 | 535.3 Million USD | -0.25% |
| 2007 Q3 | 536.64 Million USD | 5.52% |
| 2007 Q1 | 507.38 Million USD | 0.67% |
| 2006 FY | 504.03 Million USD | 4.64% |
| 2006 Q4 | 504.03 Million USD | 2.4% |
| 2006 Q3 | 492.23 Million USD | 6.14% |
| 2006 Q2 | 463.77 Million USD | -2.84% |
| 2006 Q1 | 477.35 Million USD | -0.89% |
| 2005 Q4 | 481.66 Million USD | 0.21% |
| 2005 Q3 | 480.65 Million USD | 0.41% |
| 2005 Q1 | 460.71 Million USD | 1.04% |
| 2005 Q2 | 478.7 Million USD | 3.9% |
| 2005 FY | 481.66 Million USD | 5.63% |
| 2004 FY | 455.99 Million USD | -3.95% |
| 2004 Q3 | 460.92 Million USD | -0.91% |
| 2004 Q2 | 465.17 Million USD | -1.84% |
| 2004 Q1 | 473.88 Million USD | -0.18% |
| 2004 Q4 | 455.99 Million USD | -1.07% |
| 2003 Q1 | 386.41 Million USD | -1.07% |
| 2003 Q3 | 489.79 Million USD | -0.51% |
| 2003 FY | 474.72 Million USD | 21.54% |
| 2003 Q2 | 492.29 Million USD | 27.4% |
| 2003 Q4 | 474.72 Million USD | -3.08% |
| 2002 FY | 390.59 Million USD | 7.91% |
| 2002 Q4 | 390.59 Million USD | -2.14% |
| 2002 Q3 | 399.15 Million USD | 2.39% |
| 2002 Q1 | 375.38 Million USD | 3.7% |
| 2002 Q2 | 389.85 Million USD | 3.86% |
| 2001 Q4 | 361.97 Million USD | 0.33% |
| 2001 FY | 361.97 Million USD | 13.96% |
| 2001 Q3 | 360.77 Million USD | 0.0% |
| 2000 FY | 317.62 Million USD | 2.56% |
| 1999 FY | 309.69 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 87.323% |
| Addus HomeCare Corporation | 1.02 Billion USD | 33.688% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -218.104% |
| Amedisys, Inc. | 2.06 Billion USD | 67.026% |
| American Oncology Network, Inc. | 374.45 Million USD | -81.416% |
| Astrana Health, Inc. | 933.36 Million USD | 27.218% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 58.506% |
| IMAC Holdings, Inc. | 1.14 Million USD | -59274.68% |
| biote Corp. | 155.29 Million USD | -337.436% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -1009.619% |
| COMPASS Pathways plc | 275.98 Million USD | -146.141% |
| DocGo Inc. | 490.45 Million USD | -38.508% |
| The Ensign Group, Inc. | 4.17 Billion USD | 83.739% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 15.422% |
| InnovAge Holding Corp. | 547.66 Million USD | -24.04% |
| Assure Holdings Corp. | 7.51 Million USD | -8940.684% |
| The Joint Corp. | 87.15 Million USD | -679.473% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 69.581% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -8444.207% |
| ModivCare Inc. | 1.76 Billion USD | 61.561% |
| NewGenIvf Group Limited | 1.64 Million USD | -41134.203% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -1810.177% |
| Option Care Health, Inc. | 3.32 Billion USD | 79.59% |
| P3 Health Partners Inc. | 860.96 Million USD | 21.098% |
| P3 Health Partners Inc. | 860.96 Million USD | 21.098% |
| The Pennant Group, Inc. | 539.69 Million USD | -25.871% |
| Surgery Partners, Inc. | 7.01 Billion USD | 90.322% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -13698.049% |
| Talkspace, Inc. | 142.22 Million USD | -377.649% |
| Talkspace, Inc. | 142.22 Million USD | -377.649% |
| The Oncology Institute, Inc. | 219.41 Million USD | -209.599% |
| The Oncology Institute, Inc. | 219.41 Million USD | -209.599% |